Pulmonary arteriovenous malformations may be the only clinical criterion present in genetically confirmed hereditary haemorrhagic telangiectasia. Issue 6 (14th February 2022)

• Record Type: Journal Article
• Authors: Anderson, Emily; Sharma, Lakshya; Alsafi, Ali; Shovlin, Claire L
• Is Part Of: Thorax. Volume 77:Issue 6(2022)
• Page Start: 628
• Page End: 630
• Publication Date: 2022-02-14
• Subjects: rare lung diseases -- pulmonary vasculitis; Chest -- Diseases -- Periodicals; Thorax; Chest -- Diseases; Periodicals; Periodicals; 617.54
• DOI: 10.1136/thoraxjnl-2021-218332
• Languages: English
• ISSNs: 0040-6376

Abstract

Abstract : Pulmonary arteriovenous malformations (PAVMs) result in preventable complications demanding specialty care. Underlying hereditary haemorrhagic telangiectasia (HHT) can be identified by genetic testing, if the diagnosis is considered. Retrospectively reviewing 152 unrelated adults with genetically confirmed HHT due to ACVRL1, ENG or SMAD4, we found that only 104/152 (68%) met a clinical diagnosis of HHT with three Curaçao criteria. The genetic diagnostic rate was similar for patients with three (104/137, 76%) or one to two (48/71, 68%; p=0.25) criteria. Of 83 unrelated probands with PAVM(s) and genetically-confirmed HHT, 20/83 (24%) had few, if any, features of HHT. Enhanced clinical suspicion, as well as HHT genetic testing, is recommended if one or more PAVMs are present.